The role of monosodium urate crystals in gout

September 20, 2017, Agency for Science, Technology and Research (A*STAR), Singapore
The role of monosodium urate crystals in gout
The Mortellaro group at SIgN. Credit: A*STAR Singapore Immunology Network

An attack of gout is said to be like your joint catching fire, and someone slamming it with a hammer to put out the flames. Now A*STAR researchers have identified how the build-up of monosodium urate (MSU) crystals in the joints triggers such excruciating pain, raising the prospect of new treatments.

Gout has been dubbed the disease of kings, because it is sometimes—but crucially, not always—associated with the overconsumption of alcohol, fatty or protein-rich foods. These boost levels of blood uric acid, which crystalizes in the joints: but it was unclear how these crystals caused severe .

One clue came with the discovery of inflammasomes, complexes of molecules within that respond to environmental "danger signals" by mediating the release of active message molecules called cytokines. These rally immune cells, which release further substances, resulting in excessive inflammation and pain.

Inflammasomes can become activated in response to bacterial or viral invaders, but they also respond to particulate structures such as MSU crystals. To investigate how MSU activates inflammasomes, a team led by Alessandra Mortellaro of the A*STAR Singapore Immunology Network turned to the complement system, a group of more than 20 proteins circulating in blood and tissue fluids which act as first line of immune defense.

One way of mimicking what happens in is to inject MSU crystals into the peritoneal cavity of mice; this usually triggers an influx of immune cells and inflammation. It also raises levels of two , C3a and C5a, the team found.

Experiments revealed that incubating immune cells in the presence of C5a, but not C3a, increased levels of the cytokines, IL-1β and IL-1α. "This is a hallmark of activation," says Hanif Khameneh, one of the lead investigators.

Next, the team used mice engineered without receptors for either complement protein. Those lacking C5a receptors, but not C3a receptors, failed to show the usual infiltration of , and inflammation in response to MSU crystals. Treating mice with a drug that blocks C5a receptors produced a similar result. C5a most likely triggers inflammasome activation by boosting cellular levels of , which are toxic at high levels.

The discovery could have consequences for gout treatment. Current drugs merely dampen pain and inflammation, rather than addressing its root cause. "At least in our mouse model, we've shown that complement is involved in initiating inflammation," says Khameneh. "Targeting complement may therefore benefit gout sufferers."

Explore further: Drug combination benefits patients with tophaceous gout

More information: Hanif J. Khameneh et al. C5a Regulates IL-1β Production and Leukocyte Recruitment in a Murine Model of Monosodium Urate Crystal-Induced Peritonitis, Frontiers in Pharmacology (2017). DOI: 10.3389/fphar.2017.00010

Related Stories

Drug combination benefits patients with tophaceous gout

June 9, 2017
The drug lesinurad in combination with febuxostat was better at lowering blood levels of urate than febuxostat alone in a phase III clinical trial of 324 patients with tophaceous gout. Over 12 months, significantly more patients ...

Could a ketogenic diet alleviate gout?

February 28, 2017
More than 8 million individuals in the United States have gout, a disease that can cause intense recurrent episodes of debilitating pain, inflammation, and fever. The cause of gout is the accumulation of urate crystals in ...

Titanium dioxide nanoparticles can exacerbate colitis

July 19, 2017
Titanium dioxide, one of the most-produced nanoparticles worldwide, is being used increasingly in foodstuffs. When intestinal cells absorb titanium dioxide particles, this leads to increased inflammation and damage to the ...

High fiber diets may alleviate inflammation caused by gout

January 4, 2017
New research published in the Journal of Leukocyte Biology, shows that a high-fiber diet likely inhibits gout-related inflammation caused by monosodium urate (MSU) crystals. Specifically, researchers found that diets high ...

Researchers uncover key role for microRNA in inflammatory bowel disease

May 9, 2017
An international team of researchers has discovered that a microRNA produced by certain white blood cells can prevent excessive inflammation in the intestine. The study, "Myeloid-derived miR-223 regulates intestinal inflammation ...

A braking system for immune responses: Researchers find receptor for uric acid crystals

March 20, 2014
For the first time, researchers have identified a receptor on human cells that specifically recognizes crystals. It is found on immune cells and binds uric acid crystals, which trigger gout but also control immune responses. ...

Recommended for you

Protein found in patients with severe asthma can help identify who would benefit from targeted drugs

October 22, 2018
In a novel study, researchers succeeded in identifying patients with a form of severe asthma (type 2 endotype) by measuring periostin concentrations in their airways. These patients with the type 2 (T2) endotype may benefit ...

A bad influence—the interplay between tumor cells and immune cells

October 16, 2018
Research at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) yielded new insights into the environment surrounding different types of lung tumors, and described how these complex cell ecosystems may in turn ...

Function of neutrophils during tumor progression unraveled

October 15, 2018
Researchers at The Wistar Institute have characterized the function of neutrophils, a type of white blood cells, during early stages of tumor progression, showing that they migrate from the bone marrow to distant sites and ...

Immune health maintained by meticulously ordered DNA

October 15, 2018
Walter and Eliza Hall Institute researchers have revealed how immune health is maintained by the exquisite organisation skills of a protein called Pax5.

New immunotherapy targeting blood-clotting protein

October 15, 2018
Normally, the blood protein fibrin does not enter the brain. But in several neurological disorders, the blood-brain barrier—which keeps large molecules in the blood from entering the brain—becomes abnormally permeable, ...

Enzyme that triggers autoimmune responses from T-cells in patients with MS found

October 11, 2018
A team of researchers from Switzerland, the U.S. and Spain has isolated an enzyme that triggers an autoimmune response from T-cells in patients with MS. In their paper published in the journal Science Translational Medicine, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.